[1]谢军伟,毛宇强,王京利,等.炎性肌纤维母细胞瘤诊断和治疗的研究进展[J].现代肿瘤医学,2019,27(21):3927-3930.
XIE JW,MAO YQ,WANG JL,et al.The progression of inflammatory myofibroblastic tumor in the diagnosis and treatment[J].Modern Oncology,2019,27(21):3927-3930.
[2] 刘杰,李葱,高英,等.乳腺炎性肌纤维母细胞瘤的研究进展[J].现代肿瘤医学,2019,27(14):2601-2604.
LIU J,LI C,GAO Y,et al.Research progress of inflammatory myofibroblastic tumor of breast[J].Modern Oncology,2019,27(14):2601-2604.
[3] COFFIN CM,PATEL A,PERKINS S,et al.ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor[J].Mod Pathol,2001,14(6):569-576.
[4] SHUKLA PS,MITTAL K.Inflammatory myofibroblastic tumor in female genital tract[J].Arch Pathol Lab Med,2019,143(1):122-129.
[5] COFFIN CM,WATTERSON J,PRIEST JR,et al.Extrapulmonary inflammatory myofibroblastic tumor(inflammatory pseudotumor).A clinicopathologic and immunohistochemical study of 84 cases[J].Am J Surg Pathol,1995,19(8):859-872.
[6] PARRA-HERRAN C,QUICK CM,HOWITT BE,et al.Inflammatory myofibroblastic tumor of the uterus:clinical and pathologic review of 10 cases including a subset with aggressive clinical course[J].Am J Surg Pathol,2015,39(2):157-168.
[7] MOHAMMAD N,HAIMES JD,MISHKIN S,et al.ALK is a specific diagnostic marker for inflammatory myofibroblastic tumor of the uterus[J].Am J Surg Pathol,2018,42(10):1353-1359.
[8] COOK JR,DEHNER LP,COLLINS MH,et al.Anaplastic lymphoma kinase(ALK) expression in the inflammatory myofibroblastic tumor:A comparative immunobistochemical study[J].Am J Surg Pathol,2001,25(11):1364-1371.
[9] SCHAEFER IM,HORNICK JL,SHOLL LM,et al.Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour[J].Histopathology,2017,70(7):1138-1146.
[10] 张瑜,董伟,李淑霞,等.子宫炎性肌纤维母细胞肿瘤临床及分子病理学特征[J].中华病理学杂志,2021,50(9):1020-1023.
ZHANG Y,DONG W,LI SX,et al.Clinical and molecular pathological features of uterine inflammatory myofibroblastic tumor[J].Chinese Journal of Pathology,2021,50(9):1020-1023.
[11] PREOBRAZHENSKAYA EV,IYEVLEVA AG,SULEYMANOVA AM,et al.Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors[J].Pediatr Blood Cancer,2020,67(5):e28220.
[12] CHIANG S.Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms[J].Genes Chromosomes Cancer,2021,60(3):138-146.
[13] HAIMES JD,STEWART CJR,KUDLOW BA,et al.Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1[J].Am J Surg Pathol,2017,41(6):773-780.
[14] PICKETT JL,CHOU A,ANDRICI JA,et al.Inflammatory myofibroblastic tumors of the female genital tract are under-recognized:a low threshold for ALK immunohistochemistry is required[J].Am J Surg Pathol,2017,41(10):1433-1442.
[15] DALTON BG,THOMAS PG,SHARP NE,et al.Inflammatory myofibroblastic tumors in children[J].J Pediatr Surg,2016,51(4):541-544.
[16] BENNETT JA,NARDI V,ROUZBAHMAN M,et al.Inflammatory myofibroblastic tumor of the uterus:a clinicopathological,immunohistochemical,and molecular analysis of 13 cases highlighting their broad morphologic spectrum[J].Mod Pathol,2017,30(10):1489-1503.
[17] VILLALOBOS VM,CAMIDGE DR.Targeting ALK in inflammatory myofibroblastic tumours[J].Lancet Respir Med,2018,6(6):405-407.
[18] THEILEN TM,SOERENSEN J,BOCHENNEK K,et al.Crizotinib in ALK+ inflammatory myofibroblastic tumors-current experience and future perspectives[J].Pediatr Blood Cancer,2018,65(4):e26920.